Episode 106 - Dr. Isaac Eliaz - Sepsis: The Condition Killing More People Than Cancer That Nobody Talks About

MEET THE GUEST Isaac Eliaz, MD, MS, LAc, has been a pioneer in integrative medicine since the early 1980s, focusing on cancer, immune health, detoxification, and mind-body medicine. He’s a respected clinician, researcher, author, and educator, and the author of The Survival Paradox. He is the founder and Medical Director of Amitabha Medical Clinic and Healing Center, and founder and CEO of Eliaz Therapeutics, a medical device company focused on transforming the treatment of sepsis and other life-threatening diseases.WHAT WE TALK ABOUT What sepsis really is and why it is often misunderstood as just an infection.Why sepsis is the leading cause of death globally and how it progresses in the body.The difference between a typical infection and when it becomes life-threatening sepsis. Early warning signs of sepsis and when to seek urgent medical care.How immune overreaction, not just infection, drives the severity of sepsis.The connection between sepsis, inflammation, mitochondrial dysfunction, and chronic disease.Leaky gut, the microbiome, and how barrier breakdown contributes to systemic inflammation.What galectin-3 is and its role as a key driver of inflammation and disease progression. How galectin-3 influences conditions like cancer, fibrosis, and autoimmune disease.Apheresis explained: what it is, how it works, and its role in removing inflammatory compounds.Dr. Eliaz’s research on targeting galectin-3 as a potential breakthrough treatment for sepsis. Long-term effects of sepsis, including organ damage and chronic illness.Recovery after sepsis and how to support the body’s healing process.The future of sepsis treatment, including clinical trials and emerging therapies.EPISODE RESOURCES  Eliaz Therapeutics Eliaz Therapeutics is developing XGal-3®, an FDA Breakthrough-Designated apheresis device designed to remove Galectin-3, a protein linked to the inflammatory response seen in sepsis and other critical conditions. The company is focused on advancing new treatment approaches that target the root drivers of severe inflammation and organ damage.http://www.eliaztherapeutics.com/MedComm Published ResearchNew research published in the April 2026 issue of MedComm found that selective Galectin-3 removal improved survival outcomes and reduced inflammatory markers in preclinical sepsis models, further supporting the role of Galectin-3 in critical illness. https://onlinelibrary.wiley.com/toc/26882663/2026/7/4BodyBioSupplements designed to support cellular health, mitochondrial function, and detoxification. Use code TRAILTOHEALTH for 15% OFF.https://shop.thetrailtohealth.com/BodyBio Quicksilver ScientificLiposomal supplements designed to support detoxification and reduce inflammation at a cellular level. Use code TRAILTOHEALTH for 15% OFF.https://shop.thetrailtohealth.com/QuicksilverScientific CONNECT WITH THE GUESTWebsite:https://dreliaz.org http://amitabhaclinic.com/Instagram: https://www.instagram.com/drisaaceliaz/Facebook:https://www.facebook.com/dreliaz Youtube:https://www.youtube.com/@dreliaz LinkedIn:https://www.linkedin.com/in/dr-isaac-eliaz/KEYWORDSsepsis, immune response, inflammation, galectin-3, integrative medicine, mitochondrial dysfunction, leaky gut, microbiome, detoxification, cytokines, chronic illness, immune dysregulation, apheresis, plasma exchange, systemic inflammation